{"ticker": {"uuid": "947dbfc8-8e2e-4350-a534-c5f2ef7e086b", "symbol": "069620", "name": "Daewoong Pharmaceutical Co., Ltd", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Number of shareholders of Daewoong Pharmaceutical Co., Ltd. \u2013 KRX:069620", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQc3NJT0dTYjNiRDFDY1l4SWZFYmozRTNKdS02bVlJUXAtNzE5RkM0cHJCcllhem1MMXdIdllrZXVNTmkxMW8yQ2kxZGc4Z2tUeVhlUnRYWXhwdjNhNHpDLU5OZHFiNFNEOFV0a2Nyd3E2TThBR1YwMUxLdDlZYXZCcWxsU05lU3ZOZU1pNFFfeTFRRmJ3SVd6TXk2eVhQdVdGVEFpelhn?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T19:13:19+00:00", "published_display": "13 Jul 2026 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMM PE calls off talks to acquire CGBio from Daewoong Pharmaceutical\u2019s owner", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9LSzdYS3ZvZjFYMENDUjZUS2RBWS14WHdzRnczamxhTGVKX2pQYVBqN3hsQm5PRkVNZHpYZXdXa0FnaUtGeHFUSXBSa1pWYUVHUkNub2dPUEZycUpwWkZOSDEwaVNSWkt5RnRsbVFGV0N3Q1pvUGdNRElsOA?oc=5", "source_name": "KED Global", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong takes over Turn Bio\u2019s longevity platform from Hanall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORnBEelYyNVhONFpDRTVMQUZPczNmRkpHZjRDaEVmYkNFb3NEZy11a1dnYlVTN0VEbVVUQzVWQ20tMll4THR5UXN1dnRKMlFyaml4YU4zb3UzN0N3eDNwM2p0QVlTQzhrSjRpUjY0ZjFIQkNKWVlJOWtaU2dKbF9wbmJEY2p5U2lQS3NJSHdxTXdKVFZKQTlTMUVVWFljbFc5dGFN?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong\u2019s CLOPAM patch enables injection-free, weekly semaglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb1Q1cjJ4c2lyU09ydy13bEZxeWUtdGwzdkRvZVQxbm40QkJpNVBqci1mbE5IOHAteWV4cHJNOFpURzYwNTEzVC1lVjhFQU9OT3ZUcExDN3VvcUdoc3o1SG5ZNzgzemF5SElmcGZSZ2o0aVZxNmQ5N2RpQTdncnhwM1ZPZExnSjJZWnEtbW42WUZySnA2ckRNRmpwaGp1TGVtaGlNM1FCbEo?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-13T07:00:00+00:00", "published_display": "13 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong partner Aeon lists on NYSE, seeks medical indications for embattled Jeuveau", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMzBZQmU5ak5MWUZEN0hHdkotbmllZm9Ubzd1WTRadWhzT0VGdFU3UXFxVWlSdUdrRzhmeTdHTXJpX0xhQ2pQeUJWOGRKeUdrdG5ObzR2Z01RWWo2WHVoeEhYTWMwZHBVX1VEZDRuRHlRWU1OSldxdGZlM0lDMEpaWlh4Yi0yWjhMTERGZzhaWjdnSUJhcWlQWVUwdDhUMkFMR0VSTjduMldGdldQNVotcVN0VW5US2FiNy1PZWFUckltUQ?oc=5", "source_name": "BioWorld News", "published_at": "2023-07-25T07:00:00+00:00", "published_display": "25 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong accelerates investment in CDMO business", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1kN3RqTi0zVHNOaUtaR3hfZXlmUHlqRFA1bUlGQm1WOVFfMGVBc3dHLUJNQnd6UGN3djA1bDJIZ2s5dmpjNEUwT0F0RkdYbzN6eVgycE1XXzZzVHNkQ0p0Y05zRmo2bkxlckoxTWdR?oc=5", "source_name": "KED Global", "published_at": "2023-01-18T08:00:00+00:00", "published_display": "18 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ITC favors Medytox over Daewoong in botulinum toxin strain dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5xcXZkb0J5RDRzTkRMUlFOQk9KZEZKbHhlN0lWZFpSSmRMbFRaZDVYRkZUX2tjTE9lSS15aXZaV29PUUgzVEJHdjFOYUl0a2NaUU0yYnp5c1dodw?oc=5", "source_name": "Yonhap News Agency", "published_at": "2020-07-07T07:00:00+00:00", "published_display": "07 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong Pharmaceutical's Nabota wins FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBZRW9ieWk2UFFHTFJCOHdPY1pjQWNkYVRLbnJEalRodFJvX2Zpbl9KeHdEWkMzSkJhLWNOQWlZXzcxdURpMDN6T2J2SGlUTHpvVFVhazdkWkwwdw?oc=5", "source_name": "Yonhap News Agency", "published_at": "2019-02-07T08:00:00+00:00", "published_display": "07 Feb 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong Pharm\u2019s Botoxin Receives Marketing Approval in Canada", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE5USjVoUFg3UENoeEhSeERYelVxMWdLQTJObHpIb3pZNFIybmxXbDByc1U1NnFkaWhpc3NMMkZiQjVKTzZmcHNVYktUdXNiNUFmS0cwaVZpZXowQUpqd0NQRjZ6OS1Xd0lTb09QRnF0UWdQQXc?oc=5", "source_name": "Businesskorea", "published_at": "2018-08-21T07:00:00+00:00", "published_display": "21 Aug 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Number of shareholders of Daewoong Pharmaceutical Co., Ltd. \u2013 KRX:069620", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQc3NJT0dTYjNiRDFDY1l4SWZFYmozRTNKdS02bVlJUXAtNzE5RkM0cHJCcllhem1MMXdIdllrZXVNTmkxMW8yQ2kxZGc4Z2tUeVhlUnRYWXhwdjNhNHpDLU5OZHFiNFNEOFV0a2Nyd3E2TThBR1YwMUxLdDlZYXZCcWxsU05lU3ZOZU1pNFFfeTFRRmJ3SVd6TXk2eVhQdVdGVEFpelhn?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T19:13:19+00:00", "published_display": "13 Jul 2026 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMM PE calls off talks to acquire CGBio from Daewoong Pharmaceutical\u2019s owner", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9LSzdYS3ZvZjFYMENDUjZUS2RBWS14WHdzRnczamxhTGVKX2pQYVBqN3hsQm5PRkVNZHpYZXdXa0FnaUtGeHFUSXBSa1pWYUVHUkNub2dPUEZycUpwWkZOSDEwaVNSWkt5RnRsbVFGV0N3Q1pvUGdNRElsOA?oc=5", "source_name": "KED Global", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong takes over Turn Bio\u2019s longevity platform from Hanall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORnBEelYyNVhONFpDRTVMQUZPczNmRkpHZjRDaEVmYkNFb3NEZy11a1dnYlVTN0VEbVVUQzVWQ20tMll4THR5UXN1dnRKMlFyaml4YU4zb3UzN0N3eDNwM2p0QVlTQzhrSjRpUjY0ZjFIQkNKWVlJOWtaU2dKbF9wbmJEY2p5U2lQS3NJSHdxTXdKVFZKQTlTMUVVWFljbFc5dGFN?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong\u2019s CLOPAM patch enables injection-free, weekly semaglutide", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb1Q1cjJ4c2lyU09ydy13bEZxeWUtdGwzdkRvZVQxbm40QkJpNVBqci1mbE5IOHAteWV4cHJNOFpURzYwNTEzVC1lVjhFQU9OT3ZUcExDN3VvcUdoc3o1SG5ZNzgzemF5SElmcGZSZ2o0aVZxNmQ5N2RpQTdncnhwM1ZPZExnSjJZWnEtbW42WUZySnA2ckRNRmpwaGp1TGVtaGlNM1FCbEo?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-13T07:00:00+00:00", "published_display": "13 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong partner Aeon lists on NYSE, seeks medical indications for embattled Jeuveau", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMzBZQmU5ak5MWUZEN0hHdkotbmllZm9Ubzd1WTRadWhzT0VGdFU3UXFxVWlSdUdrRzhmeTdHTXJpX0xhQ2pQeUJWOGRKeUdrdG5ObzR2Z01RWWo2WHVoeEhYTWMwZHBVX1VEZDRuRHlRWU1OSldxdGZlM0lDMEpaWlh4Yi0yWjhMTERGZzhaWjdnSUJhcWlQWVUwdDhUMkFMR0VSTjduMldGdldQNVotcVN0VW5US2FiNy1PZWFUckltUQ?oc=5", "source_name": "BioWorld News", "published_at": "2023-07-25T07:00:00+00:00", "published_display": "25 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong accelerates investment in CDMO business", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1kN3RqTi0zVHNOaUtaR3hfZXlmUHlqRFA1bUlGQm1WOVFfMGVBc3dHLUJNQnd6UGN3djA1bDJIZ2s5dmpjNEUwT0F0RkdYbzN6eVgycE1XXzZzVHNkQ0p0Y05zRmo2bkxlckoxTWdR?oc=5", "source_name": "KED Global", "published_at": "2023-01-18T08:00:00+00:00", "published_display": "18 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ITC favors Medytox over Daewoong in botulinum toxin strain dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5xcXZkb0J5RDRzTkRMUlFOQk9KZEZKbHhlN0lWZFpSSmRMbFRaZDVYRkZUX2tjTE9lSS15aXZaV29PUUgzVEJHdjFOYUl0a2NaUU0yYnp5c1dodw?oc=5", "source_name": "Yonhap News Agency", "published_at": "2020-07-07T07:00:00+00:00", "published_display": "07 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong Pharmaceutical's Nabota wins FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBZRW9ieWk2UFFHTFJCOHdPY1pjQWNkYVRLbnJEalRodFJvX2Zpbl9KeHdEWkMzSkJhLWNOQWlZXzcxdURpMDN6T2J2SGlUTHpvVFVhazdkWkwwdw?oc=5", "source_name": "Yonhap News Agency", "published_at": "2019-02-07T08:00:00+00:00", "published_display": "07 Feb 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daewoong Pharm\u2019s Botoxin Receives Marketing Approval in Canada", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE5USjVoUFg3UENoeEhSeERYelVxMWdLQTJObHpIb3pZNFIybmxXbDByc1U1NnFkaWhpc3NMMkZiQjVKTzZmcHNVYktUdXNiNUFmS0cwaVZpZXowQUpqd0NQRjZ6OS1Xd0lTb09QRnF0UWdQQXc?oc=5", "source_name": "Businesskorea", "published_at": "2018-08-21T07:00:00+00:00", "published_display": "21 Aug 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 53, "total_relevant": 9, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 9, "score": 50, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 4.2, "count": 7}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.45, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 131900.0, "latest_week": "2026-07-10", "one_week_move": -0.5, "four_week_move": 9.8, "twelve_week_move": -14.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.769326, "market_dynamics_buy_signal": false, "relative_strength": -46.226534, "fair_value_gap": -0.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.9966, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.5% over one week, +9.8% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "BioWorld News", "count": 3}, {"label": "KED Global", "count": 2}, {"label": "Yonhap News Agency", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Businesskorea", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Regulatory and legal", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.5% over one week, +9.8% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Number of shareholders of Daewoong Pharmaceutical Co., Ltd. \u2013 KRX:069620"}], "updated_at": "2026-07-17T20:37:50.461173+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}